{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:25:54Z","timestamp":1792891554715,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jaci.2013.07.049","type":"journal-article","created":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T08:46:36Z","timestamp":1382604396000},"page":"429-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":286,"title":["Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A\u00a0systematic review"],"prefix":"10.1016","volume":"133","author":[{"given":"Evelien","family":"Roekevisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis Ira","family":"Spuls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Kuester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Limpens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2013.07.049_bib1","first-page":"345","article-title":"Outpatient care and medical treatment of children and adults with atopic eczema","volume":"7","author":"Schmitt","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaci.2013.07.049_bib2","first-page":"13","article-title":"Grading of the severity of atopic dermatitis","volume":"144","author":"Rajka","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.jaci.2013.07.049_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000245677","article-title":"Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis","volume":"195","author":"Kunz","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2013.07.049_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.47102\/annals-acadmedsg.V33N3p311","article-title":"Cyclosporin in the treatment of severe atopic dermatitis: a retrospective study","volume":"33","author":"Lee","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.jaci.2013.07.049_bib5","unstructured":"Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions, version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available at: www.cochrane-handbook.org. Accessed October 17, 2013."},{"key":"10.1016\/j.jaci.2013.07.049_bib6","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2013.07.049_bib7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1748-720X.2012.00670.x","article-title":"Bias in the evaluation of conflict of interest policies","volume":"40","author":"Sharek","year":"2012","journal-title":"J Law Med Ethics"},{"key":"10.1016\/j.jaci.2013.07.049_bib8","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1398-9995.2012.02874.x","article-title":"Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting","volume":"67","author":"Schmitt","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2013.07.049_bib9","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.jaci.2007.08.011","article-title":"What are the best outcome measurements for\u00a0atopic eczema? A\u00a0systematic review","volume":"120","author":"Schmitt","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.07.049_bib10","first-page":"2","article-title":"GRADE: assessing the quality of evidence for diagnostic recommendations","volume":"149","author":"Schunemann","year":"2008","journal-title":"ACP J Club"},{"key":"10.1016\/j.jaci.2013.07.049_bib11","first-page":"139","article-title":"High doses intravenous immunoglobulin versus oral cyclosporine in the treatment of severe atopic dermatitis","volume":"4","author":"Bemanian","year":"2005","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2013.07.049_bib12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1365-2133.2002.04989.x","article-title":"Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial","volume":"147","author":"Berth-Jones","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib13","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1365-2222.2006.02558.x","article-title":"Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Berth-Jones","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2013.07.049_bib14","first-page":"209","article-title":"A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults","volume":"11","author":"Capella","year":"2001","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000318861","article-title":"The efficacy and safety of a Chinese herbal product (Xiao-Feng-San) for the treatment of refractory atopic dermatitis: a randomized, double-blind, placebo-controlled trial","volume":"155","author":"Cheng","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2013.07.049_bib16","first-page":"653","article-title":"A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life","volume":"42","author":"Czech","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/000155501750208137","article-title":"Comparison of cyclosporin and UVAB phototherapy for intermittent one-year treatment of atopic dermatitis","volume":"81","author":"Granlund","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2013.07.049_bib18","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jaad.2010.04.027","article-title":"Enteric-coated mycophenolate sodium versus cyclosporin A\u00a0as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial","volume":"64","author":"Haeck","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0190-9622(93)70026-P","article-title":"Recombinant interferon gamma therapy for atopic dermatitis","volume":"28","author":"Hanifin","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2133.2000.03241.x","article-title":"Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy","volume":"142","author":"Harper","year":"2000","journal-title":"Br\u00a0J Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.289.6446.651","article-title":"Combined oral and nasal beclomethasone diproprionate in children with atopic eczema: a randomised controlled trial","volume":"289","author":"Heddle","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jaci.2013.07.049_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2133.2007.07941.x","article-title":"Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study","volume":"157","author":"Hon","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib23","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1067\/mjd.2000.104793","article-title":"Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma","volume":"42","author":"Jang","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4168\/aair.2011.3.2.89","article-title":"Long-term efficacy of intravenous immunoglobulin therapy for moderate to severe childhood atopic dermatitis","volume":"3","author":"Jee","year":"2011","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2013.07.049_bib25","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/0011-393X(95)85143-7","article-title":"A randomized, double-blind, placebo-controlled crossover trial of systemic flunisolide in the treatment of children with severe atopic dermatitis","volume":"56","author":"La Rosa","year":"1995","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.jaci.2013.07.049_bib26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(06)68340-2","article-title":"Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial","volume":"367","author":"Meggitt","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2013.07.049_bib27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2133.1994.tb02936.x","article-title":"Maintenance treatment with cyclosporin in atopic eczema","volume":"130","author":"Munro","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2222.2004.1907.x","article-title":"Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study","volume":"34","author":"Pacor","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2013.07.049_bib29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1365-2133.2002.04833.x","article-title":"A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis","volume":"147","author":"Paul","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1034\/j.1399-3038.2001.012003154.x","article-title":"Montelukast in the treatment of children with moderate-to-severe atopic dermatitis: a pilot study","volume":"12","author":"Pei","year":"2001","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2013.07.049_bib31","first-page":"85","article-title":"Effectiveness of montelukast in the treatment of atopic dermatitis","volume":"15","author":"Rahman","year":"2006","journal-title":"Mymensingh Med J"},{"key":"10.1016\/j.jaci.2013.07.049_bib32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2133.1993.tb03170.x","article-title":"Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A\u00a0randomized, double-blind, placebo-controlled trial","volume":"129","author":"Salek","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2133.2009.09561.x","article-title":"Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial","volume":"162","author":"Schmitt","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2011.03.024","article-title":"A randomized trial of methotrexate versus azathioprine for severe atopic eczema","volume":"128","author":"Schram","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.07.049_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0140-6736(92)92424-E","article-title":"Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis [erratum appears in Lancet 1992;340:188]","volume":"340","author":"Sheehan","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2013.07.049_bib36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.1992.tb07817.x","article-title":"A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema","volume":"126","author":"Sheehan","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0140-6736(91)90134-B","article-title":"Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis","volume":"338","author":"Sowden","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2013.07.049_bib38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0190-9622(94)70068-0","article-title":"A double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of thymopentin as an adjunctive treatment in atopic dermatitis","volume":"30","author":"Stiller","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib39","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2133.1994.tb13111.x","article-title":"Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study","volume":"130","author":"van Joost","year":"1994","journal-title":"Br\u00a0J Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jaad.2004.12.011","article-title":"Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial","volume":"53","author":"Veien","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2340\/0001555570323329","article-title":"Antipruritic effect of oral cyclosporin A\u00a0in atopic dermatitis","volume":"70","author":"Wahlgren","year":"1990","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2013.07.049_bib42","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1365-2133.2005.06674.x","article-title":"Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial","volume":"152","author":"Wolff","year":"2005","journal-title":"Br J Dermatol"},{"issue":"Suppl. 48","key":"10.1016\/j.jaci.2013.07.049_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2133.1996.tb00704.x","article-title":"The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimens","volume":"135","author":"Zonneveld","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000018065","article-title":"Comparison of two formulations of cyclosporin A in the treatment of severe atopic dermatitis. A double-blind, single-centre, cross-over pilot study","volume":"198","author":"Zurbriggen","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2013.07.049_bib45","unstructured":"GRADE working group. Available at: http:\/\/www.gradeworkinggroup.org\/publications. Accessed October 17, 2013."},{"key":"10.1016\/j.jaci.2013.07.049_bib46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaci.2006.03.045","article-title":"Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology\/American Academy of Allergy, Asthma and Immunology\/PRACTALL Consensus Report","volume":"118","author":"Akdis","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.07.049_bib47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaad.2003.08.003","article-title":"Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)\/American Academy of Dermatology Association \u201cAdministrative Regulations for Evidence-Based Clinical Practice Guidelines.\u201d","volume":"50","author":"Hanifin","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib48","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1365-2133.2008.08502.x","article-title":"In\u00a0vitro and clinical immunomodulatory effects of a novel Pentaherbs concoction for atopic dermatitis","volume":"158","author":"Leung","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib49","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1468-3083.2012.04636.x","article-title":"Guidelines for treatment of atopic eczema (atopic dermatitis) Part II","volume":"26","author":"Ring","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2013.07.049_bib50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaci.2012.12.672","article-title":"Atopic dermatitis: a practice parameter update 2012","volume":"131","author":"Schneider","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.07.049_bib51","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0140-6736(92)92208-W","article-title":"Toxicity of Chinese herbal remedies","volume":"340","author":"Graham-Brown","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2013.07.049_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1749-8546-6-17","article-title":"Chinese herbal medicine research in eczema treatment","volume":"6","author":"Hon","year":"2011","journal-title":"Chin Med"},{"key":"10.1016\/j.jaci.2013.07.049_bib53","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/bmj.299.6708.1156","article-title":"Hepatotoxicity of herbal remedies","volume":"299","author":"MacGregor","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2013.07.049_bib54","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0140-6736(92)92209-X","article-title":"Fatal hepatitis after herbal tea","volume":"340","author":"Mostefa-Kara","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2013.07.049_bib55","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1468-3083.2012.04635.x","article-title":"Guidelines for treatment of atopic eczema (atopic dermatitis) part I","volume":"26","author":"Ring","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2013.07.049_bib56","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1346-8138.2009.00706.x","article-title":"Guidelines for management of atopic dermatitis","volume":"36","author":"Saeki","year":"2009","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2013.07.049_bib57","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMcp042803","article-title":"Clinical practice. Atopic dermatitis","volume":"352","author":"Williams","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913013006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913013006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:48:24Z","timestamp":1758790104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674913013006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0091674913013006"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2013.07.049","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A\u00a0systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2013.07.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}